News

CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company focused on the development of innovative therapies, announces the signing of a binding ...
Urges Shareholders to Vote "FOR" ONLY the Eight Brookdale Nominees Listed on the BLUE Proxy Card Visit VoteBrookdaleBLUE.com for More Information NASHVILLE, Tenn.
Welcome to CI&T earnings call for the first quarter of 2025. I am Eduardo Galvao, Director of Investor Relations at CI&T. Joining me today are Cesar Gon, our Founder and CEO; Bruno Guicardi, Founder ...
Q3 2025 Earnings Conference Call May 13, 2025 8:00 AM ETCompany ParticipantsClaus Sauter - CEOOlaf Tröber - CFOConference ...